Italy, Bologna 
Dr. Claudio Cerchione is an Italian hematologist and clinical researcher with extensive expertise in hematologic malignancies, particularly multiple myeloma and acute leukemias. He is actively involved in early-phase clinical trials and international collaborations, contributing significantly to translational research and innovative therapeutic strategies in onco-hematology.
Current Position
- Dirigente Medico Ricercatore (Consultant Hematologist and Researcher), Phase 1 Trials Board, Hematology Unit, IRST IRCCS (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Meldola, Italy
- Adjunct Professor, Department of Pharmacology and Biotechnology, University of Bologna, Italy
Education
- PhD in Biomedical and Surgical Treatments, University Federico II, Naples, Italy (2017, cum laude)
- Fellowship (Residency) in Hematology, University Federico II, Naples, Italy (2014, cum laude)
- MD, University Federico II, Naples, Italy (2008, cum laude)
- European Hematology Association (EHA) Certification (2018)
Professional Experience
- Consultant Hematologist, IRST IRCCS Meldola, Italy (2018–present), including involvement in Phase 1 clinical trials
- Pediatric Onco-Hematology, A.O.R.N. Santobono-Pausilipon Hospital, Naples (2014–2018)
- Medical practice within ASL Napoli 1, including correctional healthcare (2011–2014)
- Home care physician in adult and pediatric hematology
International Experience
- Ongoing collaboration with the Leukemia Department, MD Anderson Cancer Center, Houston, USA
- Clinical and research training experiences in Portugal (University of Coimbra) and Germany (University of Bonn)
Research & Clinical Interests
- Multiple Myeloma and MGUS (diagnostics, relapsed/refractory treatments, transplantation)
- Acute Myeloid and Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia and myeloproliferative neoplasms
- Myelodysplastic syndromes
- Lymphomas and chronic lymphocytic leukemia
- Pediatric hematologic malignancies
- Infectious complications in hematologic patients
- Bone marrow transplantation and advanced imaging techniques
Clinical Trials & Research Activity
Dr. Cerchione serves as Principal Investigator and sub-investigator in numerous Phase 1–3 international clinical trials in multiple myeloma and acute leukemias, including studies involving novel immunotherapies, targeted agents, and combination regimens. He is also involved in real-world observational studies and translational research initiatives.
Professional Memberships & Leadership
President and Founder, SOHO Italy (Society of Hematologic Oncology)
Board Member, EMA Scientific Advisory Group Onco-Hematology
Board Member, European Myeloma Network (EMN)
Member: EHA, ASH, SIE, SIES, AIEOP, AIL
Ambassador, Society of Hematologic Oncology (SOHO), MD Anderson Cancer Center
Editorial & Scientific Roles
- Associate Editor: Frontiers in Oncology, Supportive Care in Cancer, Journal of Clinical Medicine, and others
- Guest Editor for multiple international journals
- Board Member, Clinical Research Expert Review Panel (Cancer Research UK)
- Expert Board Member, Czech Health Research Council
Awards & Honors
- Winner, Clinical Research Training Program in Hematology (EHA)
- Multiple international travel grants (EHA, SOHO, SIE, SIES)
- iAcademy Awards (2013, 2014)
- Rotary Club Volunteer Prize (2018)
Teaching & Academic Roles
- Adjunct Professor, University of Bologna
- Research Teaching Assistant in Hematology at University of Ferrara and University Federico II, Naples
- Scientific lead and educator in multiple national and international hematology courses
Publications
Author and co-author of numerous peer-reviewed publications in leading hematology and oncology journals, focusing on multiple myeloma, leukemia, supportive care, and translational research.